Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant - PA: Patient-Oriented Research: Early-Career Investigator

University of Calgary

$100,000.00

EVOLVE-Cog: A prospective cohort study of the cognitive and neuropsychiatric effects of iatrogenic brain infarcts and their prevention by acetylsalicylic acid

EF 2021-22

Résumé
Patients often end up with tiny strokes after surgery or minimally invasive procedures, like coiling for brain aneurysms. These tiny strokes can be seen on MRI scans. When they are caused by a procedure, they are termed "iatrogenic". While we don't know much about their effects in otherwise healthy people, we know that small strokes can cause memory problems when they build up over time in older people with vascular disease. Recent studies have indicated that iatrogenic strokes can cause similar problems, but no treatments have been shown to help with these problems. A randomized controlled trial, EVOLVE, is testing whether taking acetylsalicylic acid (ASA, also called aspirin) will reduce the number of strokes after aneurysm coiling. We want to follow these patients for up to a year after coiling to check whether treatment with ASA also results in better memory and mental health. All patients in the trial will have a brain MRI 12-48 hours after coiling. For our study, we will check the patients for temporary confusion, also called delirium, that can happen after operations. We will also do detailed tests of memory, thinking, and mental health before, shortly after, and up to 1 year after coiling. We will ask patients about their quality of life. We will ask their care partners about how the patients are doing in their daily life. We think that patients getting ASA will do better on the tests and have delirium less often. Based on our prior work, we also expect that patients with more iatrogenic strokes on their brain scan will do worse than those with fewer or no strokes. Our study will provide the most detailed knowledge of long-term effects of iatrogenic strokes until now. If we find that patients taking ASA do better on our tests, this will help change how we manage thousands of patients treated with procedures like coiling around the world. By understanding the effects of iatrogenic strokes, we can also become better at testing treatments to prevent them.
Programme
Project Grant - PA: Patient-Oriented Research: Early-Career Investigator
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
456839
Name
Ganesh Aravind
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
EVOLVE-Cog: A prospective cohort study of the cognitive and neuropsychiatric effects of iatrogenic brain infarcts and their prevention by acetylsalicylic acid
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Patient-Oriented Research: Early-Career Investigator
Keyworddelim
Acetylsalicylic Acid; Activities Of Daily Living; Clinical Manifestations; Cognition; Delirium; Iatrogenic Brain Infarcts; Mild Behavioural Impairment; Neuropsychiatric; Quality Of Life; Silent Brain Infarcts
Abstract
Patients often end up with tiny strokes after surgery or minimally invasive procedures, like coiling for brain aneurysms. These tiny strokes can be seen on MRI scans. When they are caused by a procedure, they are termed "iatrogenic". While we don't know much about their effects in otherwise healthy people, we know that small strokes can cause memory problems when they build up over time in older people with vascular disease. Recent studies have indicated that iatrogenic strokes can cause similar problems, but no treatments have been shown to help with these problems. A randomized controlled trial, EVOLVE, is testing whether taking acetylsalicylic acid (ASA, also called aspirin) will reduce the number of strokes after aneurysm coiling. We want to follow these patients for up to a year after coiling to check whether treatment with ASA also results in better memory and mental health. All patients in the trial will have a brain MRI 12-48 hours after coiling. For our study, we will check the patients for temporary confusion, also called delirium, that can happen after operations. We will also do detailed tests of memory, thinking, and mental health before, shortly after, and up to 1 year after coiling. We will ask patients about their quality of life. We will ask their care partners about how the patients are doing in their daily life. We think that patients getting ASA will do better on the tests and have delirium less often. Based on our prior work, we also expect that patients with more iatrogenic strokes on their brain scan will do worse than those with fewer or no strokes. Our study will provide the most detailed knowledge of long-term effects of iatrogenic strokes until now. If we find that patients taking ASA do better on our tests, this will help change how we manage thousands of patients treated with procedures like coiling around the world. By understanding the effects of iatrogenic strokes, we can also become better at testing treatments to prevent them.
Competitiondate
202109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ganesh, Aravind; Almekhlafi, Mohammed A; Goyal, Mayank
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~